Entities / Company
Pfizer PFE.
Czech company
- Reports this week
- 0
- Active events
- 0
- Connections
- 16
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
Gone quiet
No new reports in 90+ days-
Leading pharmaceutical companies including Novartis, Eli Lilly, Pfizer, and Bristol Myers Squibb are focused on cutting-edge oncology approaches amid projections of 2 million new cancer cases in the US.Some support1 report1 development inside
-
The FDA is reviewing TAR-200 for approval, a process involving major pharmaceutical companies like Merck, AstraZeneca, and Pfizer in the oncology space.Some support3 reports
-
Diverse companies including BP, Pfizer, and Caterpillar reported significant earnings surprises or misses in Q2 on August 5, 2025.Some support2 reports1 development inside
-
Boston Scientific and Pfizer operate in emerging markets.Some support1 report
-
FDA approved updated COVID-19 vaccines on August 29, 2025, involving companies like Novavax, Moderna, and Pfizer.Well supported6 reports1 development inside
No events began in the chosen period. Widen it, or reset.
Around Pfizer PFE this week
News at the entities that move Pfizer PFE most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Pfizer PFE
-
SpaceX Mentioned togetherThe UK defence ministry has adopted and begun using SpaceX's Starshield and Starlink services.Moves Pfizer PFE
Connections
The 2 strongest of 16, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.History
Events by the month they beganJune 2026
5 events- Leading pharmaceutical companies including Novartis, Eli Lilly, Pfizer, and Bristol Myers Squibb are focused on cutting-edge oncology approaches amid projections of 2 million new cancer cases in the US.
- The FDA is reviewing TAR-200 for approval, a process involving major pharmaceutical companies like Merck, AstraZeneca, and Pfizer in the oncology space.
- Diverse companies including BP, Pfizer, and Caterpillar reported significant earnings surprises or misses in Q2 on August 5, 2025.
- Boston Scientific and Pfizer operate in emerging markets.
- FDA approved updated COVID-19 vaccines on August 29, 2025, involving companies like Novavax, Moderna, and Pfizer.